Cellular mesoblastic nephroma in infants and children: Report of four cases and review of the literature

Author:

Geramizadeh Bita12ORCID,Kashkooe Ali3,Keshavarz Pedram4,Zareifar Soheila5,Foroutan Hamidreza6

Affiliation:

1. Department of Pathology, Medical School of Shiraz University, Shiraz University of Medical Sciences, Shiraz, Iran

2. Transplant Research Center, Shiraz University of medical Sciences, Shiraz, Iran

3. Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran

4. Department of Radiology, Medical Imaging Research Center, Shiraz University of Medical School, Shiraz, Iran

5. Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

6. Department of Pediatric Surgery, Shiraz University of Medical Sciences, Shiraz, Iran

Abstract

Background: Cellular mesoblastic nephroma is rare after infancy, and there are many controversial reports about its clinical presentation and treatment as well as outcome in infants, young children, and adolescents. Objectives: In this report, we will discuss our experience with four cases of cellular mesoblastic nephroma presented from infancy to childhood (from 18 months of age to 11 years of age). Cases: During 10 years, we had the experience of 4 cases of pediatric renal tumor with the diagnosis of cellular mesoblastic nephroma, which have been followed between 1 year and 6 years. There were three male and one female patients with the age of 1.5, 2, 2, and 11 years. These tumors showed variable characteristics according to the number of mitosis, proliferative rate, necrosis, immunohistochemical markers, and metastatic potential; however, despite of all of these variabilities, all of these patients have done well and all have been well at the end of study. Conclusion: Pediatric renal tumors with the histologic diagnosis of cellular mesoblastic nephroma have good outcome even with metastasis, mitosis, and high proliferative rate.

Publisher

SAGE Publications

Subject

General Medicine

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3